Published in Biochemistry on June 23, 2009
Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem (2011) 1.27
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog (2011) 1.24
SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog (2010) 1.15
Clinical uses of botulinum neurotoxins: current indications, limitations and future developments. Toxins (Basel) (2012) 1.04
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Nature (2013) 1.01
Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA . Biochemistry (2010) 1.01
Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins. J Cell Sci (2012) 0.96
Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering. Toxins (Basel) (2010) 0.95
Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding. J Mol Biol (2010) 0.93
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A). PLoS Pathog (2013) 0.91
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Nat Struct Mol Biol (2016) 0.90
Unique ganglioside recognition strategies for clostridial neurotoxins. J Biol Chem (2011) 0.90
Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A. FEBS Lett (2014) 0.90
Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons. J Biol Chem (2011) 0.89
Towards new uses of botulinum toxin as a novel therapeutic tool. Toxins (Basel) (2011) 0.88
Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. J Biol Chem (2012) 0.88
Structure of dual receptor binding to botulinum neurotoxin B. Nat Commun (2013) 0.87
Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D. Biochem Biophys Res Commun (2010) 0.87
Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a. J Neurosci (2015) 0.87
Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine. PLoS Pathog (2012) 0.86
Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH. Biochemistry (2012) 0.85
Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain. PLoS One (2012) 0.85
Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons. Cell Rep (2016) 0.84
Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin. Prog Biophys Mol Biol (2015) 0.83
Targeted secretion inhibitors-innovative protein therapeutics. Toxins (Basel) (2010) 0.83
Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II. Structure (2013) 0.83
Unique biological activity of botulinum D/C mosaic neurotoxin in murine species. Infect Immun (2012) 0.82
Subunit vaccine efficacy against Botulinum neurotoxin subtypes. Vaccine (2011) 0.81
Enhancing the protective immune response against botulism. Infect Immun (2013) 0.81
Beltless translocation domain of botulinum neurotoxin A embodies a minimum ion-conductive channel. J Biol Chem (2011) 0.80
Botulinum neurotoxin type-A enters a non-recycling pool of synaptic vesicles. Sci Rep (2016) 0.80
Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function. Toxicon (2013) 0.79
Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling. PLoS One (2015) 0.78
Unique ganglioside binding by botulinum neurotoxins C and D-SA. FEBS J (2011) 0.78
The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo. Clin Vaccine Immunol (2013) 0.78
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature. Toxins (Basel) (2017) 0.77
Tetanus neurotoxin utilizes two sequential membrane interactions for channel formation. J Biol Chem (2014) 0.77
Emerging opportunities for serotypes of botulinum neurotoxins. Toxins (Basel) (2012) 0.77
Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D. Biochimie (2013) 0.77
OnabotulinumtoxinA for chronic migraine: a critical appraisal. Ther Clin Risk Manag (2015) 0.76
SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons. Neurotox Res (2015) 0.76
A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation. Infect Immun (2015) 0.76
Bacterial Signaling to the Nervous System via Toxins and Metabolites. J Mol Biol (2017) 0.75
Multiple domains of tetanus toxin direct entry into primary neurons. Traffic (2014) 0.75
Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin. Toxins (Basel) (2016) 0.75
A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding. Sci Rep (2017) 0.75
Botulinum neurotoxin A1 likes it double sweet. Nat Struct Mol Biol (2016) 0.75
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature (1992) 8.39
Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol (1983) 7.55
SV2 is the protein receptor for botulinum neurotoxin A. Science (2006) 4.51
Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol (1998) 4.21
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun (2005) 3.06
Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States. Appl Microbiol (1967) 2.69
Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem (2004) 2.24
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature (2006) 2.20
Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon (2001) 2.05
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett (2006) 2.04
Preliminary report on the isolation of an apparently new type of CI. botulinum. Acta Pathol Microbiol Scand (1960) 2.02
Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature (2006) 1.97
Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol (2003) 1.81
The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol (2004) 1.73
Gangliosides as components of lipid membrane domains. Glycobiology (2006) 1.71
Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem (2004) 1.67
Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin. J Biol Chem (1996) 1.66
Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell (2008) 1.66
Botulism: the present status of the disease. Curr Top Microbiol Immunol (1995) 1.58
Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem (1994) 1.57
Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction. PLoS Pathog (2008) 1.54
The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J Biol Chem (2001) 1.42
Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol (2004) 1.42
Botulism due to Clostridium baratii type F toxin. J Clin Microbiol (2002) 1.40
Functional characterisation of tetanus and botulinum neurotoxins binding domains. J Cell Sci (1999) 1.39
Subunit vaccine against the seven serotypes of botulism. Infect Immun (2007) 1.39
Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J Mol Biol (2008) 1.35
Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu Rev Microbiol (1999) 1.26
The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett (1996) 1.25
Sequence of the gene encoding type F neurotoxin of Clostridium botulinum. FEMS Microbiol Lett (1992) 1.24
Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J Biol Chem (2002) 1.23
Interaction between Clostridium botulinum neurotoxin and gangliosides. Biochim Biophys Acta (1980) 1.18
Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity. J Mol Biol (2003) 1.18
SV2B regulates synaptotagmin 1 by direct interaction. J Biol Chem (2004) 1.17
Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J Cell Biol (2007) 1.15
Structure of the receptor binding fragment HC of tetanus neurotoxin. Nat Struct Biol (1997) 1.14
Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry (2007) 1.14
Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb Pathog (1998) 1.11
SV2A and SV2C contain a unique synaptotagmin-binding site. Mol Cell Neurosci (2005) 1.09
Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. Biochim Biophys Acta (1999) 1.07
The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J Neurochem (1993) 1.06
Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b. Biochemistry (2004) 1.02
First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol (2005) 1.00
Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neurosci Lett (1996) 0.99
Molecular basis for tetanus toxin coreceptor interactions. Biochemistry (2008) 0.96
Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins. Biochim Biophys Acta (2005) 0.90
Binding of Clostridium botulinum neurotoxin to gangliosides. J Biochem (1986) 0.89
Gangliosides and glycosphingolipids of peripheral nervous system myelins--a minireview. Neurochem Res (1998) 0.87
Common binding site for disialyllactose and tri-peptide in C-fragment of tetanus neurotoxin. Proteins (2005) 0.87
Solubilization and characterization of the acceptor for Clostridium botulinum type B neurotoxin from rat brain synaptic membranes. Biochim Biophys Acta (1993) 0.85
Roles of complex gangliosides at the neuromuscular junction. Ann N Y Acad Sci (2003) 0.79
Keratan sulfate-containing proteoglycans in sheep brain with particular reference to phosphacan and synaptic vesicle proteoglycan isoforms. Biomed Chromatogr (2009) 0.78
[Studies on Clostridium botulinum type F. I. Properties of selected cultures of the Langeland strain]. Med Dosw Mikrobiol (1968) 0.77
Regulation of axonal development by plasma membrane gangliosides. J Neurochem (2007) 0.77
The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67
Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell (2007) 5.94
A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24
A memory retrieval-extinction procedure to prevent drug craving and relapse. Science (2012) 4.04
Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog (2008) 2.77
Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology (2005) 2.32
PP1-mediated dephosphorylation of phosphoproteins at mitotic exit is controlled by inhibitor-1 and PP1 phosphorylation. Nat Cell Biol (2009) 2.20
Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi (2011) 2.15
Drosophila odorant receptors are novel seven transmembrane domain proteins that can signal independently of heterotrimeric G proteins. Insect Biochem Mol Biol (2008) 2.07
FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal (2005) 2.06
Eukaryotic protein domains as functional units of cellular evolution. Sci Signal (2009) 2.06
The incidence of lower eyelid malposition after facial fracture repair: a retrospective study and meta-analysis comparing subtarsal, subciliary, and transconjunctival incisions. Plast Reconstr Surg (2009) 2.05
Reduction in voltage-gated K+ currents in primary cultured rat pancreatic beta-cells by linoleic acids. Endocrinology (2005) 2.00
Bacterial cytotoxins: targeting eukaryotic switches. Nat Rev Microbiol (2005) 1.98
Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2). Proc Natl Acad Sci U S A (2010) 1.96
Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J Biol Chem (2005) 1.93
Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron (2002) 1.91
Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem (2002) 1.88
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Proc Natl Acad Sci U S A (2007) 1.85
Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.84
Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol (2009) 1.81
Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors. J Comb Chem (2006) 1.79
Global genome expression analysis of rice in response to drought and high-salinity stresses in shoot, flag leaf, and panicle. Plant Mol Biol (2007) 1.76
SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int J Mol Med (2005) 1.73
Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice. Gastroenterology (2008) 1.72
Using single-particle tracking to study nuclear trafficking of viral genes. Biophys J (2004) 1.72
A microarray analysis of the rice transcriptome and its comparison to Arabidopsis. Genome Res (2005) 1.71
Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res (2004) 1.68
A transcriptomic analysis of superhybrid rice LYP9 and its parents. Proc Natl Acad Sci U S A (2009) 1.67
Molecular data and ecological niche modelling reveal a highly dynamic evolutionary history of the East Asian Tertiary relict Cercidiphyllum (Cercidiphyllaceae). New Phytol (2012) 1.66
Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic (2007) 1.64
Acquired entropion associated with the transconjunctival incision for facial fracture management. J Craniofac Surg (2009) 1.64
Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci (2012) 1.63
Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J Biol Chem (2003) 1.60
Polymorphism of antigen MPT64 in Mycobacterium tuberculosis strains. J Clin Microbiol (2013) 1.56
Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res (2007) 1.55
Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450. J Biol Chem (2009) 1.54
Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways. Regul Pept (2013) 1.54
Unique substrate recognition by botulinum neurotoxins serotypes A and E. J Biol Chem (2006) 1.54
Reducing exposure to avian influenza H7N9. Lancet (2013) 1.50
ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One (2012) 1.50
Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool. Proc Natl Acad Sci U S A (2006) 1.49
The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability. Protein Expr Purif (2004) 1.45
Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain. Proc Natl Acad Sci U S A (2010) 1.40
Subunit vaccine against the seven serotypes of botulism. Infect Immun (2007) 1.39
Complete genome sequences of Mycobacterium tuberculosis strains CCDC5079 and CCDC5080, which belong to the Beijing family. J Bacteriol (2011) 1.38
Altered contractile phenotypes of intestinal smooth muscle in mice deficient in myosin phosphatase target subunit 1. Gastroenterology (2013) 1.38
The structure of a binary complex between a mammalian mevalonate kinase and ATP: insights into the reaction mechanism and human inherited disease. J Biol Chem (2002) 1.37
Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells. J Bone Miner Res (2007) 1.35
Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu Rev Microbiol (2008) 1.35
In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun (2002) 1.35
Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II. Mol Pharmacol (2007) 1.33
Complete genome sequence of the probiotic Lactobacillus plantarum ST-III. J Bacteriol (2010) 1.32
Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii. Nat Rev Microbiol (2013) 1.31
Mechanism of substrate recognition by botulinum neurotoxin serotype A. J Biol Chem (2007) 1.30
Molecular ecology of pyrethroid knockdown resistance in Culex pipiens pallens mosquitoes. PLoS One (2010) 1.27
Regulation of interdomain interactions by calmodulin in inducible nitric-oxide synthase. J Biol Chem (2009) 1.25
The tight junction protein CAR regulates cardiac conduction and cell-cell communication. J Exp Med (2008) 1.23
Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin Vaccine Immunol (2008) 1.22
Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clin Cancer Res (2011) 1.21
Tuning the band gap of graphene nanoribbons synthesized from molecular precursors. ACS Nano (2013) 1.21
Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency. Proc Natl Acad Sci U S A (2011) 1.21
The clinical experience of double-orifice tricuspid valve. Heart Lung Circ (2012) 1.20
The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology (2003) 1.19
Crystal structure of rat short chain acyl-CoA dehydrogenase complexed with acetoacetyl-CoA: comparison with other acyl-CoA dehydrogenases. J Biol Chem (2002) 1.19
PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest. J Bone Miner Res (2005) 1.18
Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins. Mol Microbiol (2002) 1.17
Role of financial and social hardships in asthma racial disparities. Pediatrics (2014) 1.16
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS. J Biol Chem (2002) 1.16
Neural modulation tuning characteristics scale to efficiently encode natural sound statistics. J Neurosci (2010) 1.16
Crystal structures of human glutaryl-CoA dehydrogenase with and without an alternate substrate: structural bases of dehydrogenation and decarboxylation reactions. Biochemistry (2004) 1.16
Serial analysis of gene expression study of a hybrid rice strain (LYP9) and its parental cultivars. Plant Physiol (2005) 1.15
Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding. J Biol Chem (2011) 1.15
Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors. J Am Chem Soc (2010) 1.14
Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists. Bioorg Med Chem Lett (2004) 1.14
Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry (2007) 1.14
Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells. J Biol Chem (2003) 1.14
IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol (2013) 1.14
Myosin light chain kinase is necessary for tonic airway smooth muscle contraction. J Biol Chem (2009) 1.14
DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease. Hum Mol Genet (2008) 1.13
Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells. Nanotechnology (2006) 1.13
Twisting carbon nanotube fibers for both wire-shaped micro-supercapacitor and micro-battery. Adv Mater (2012) 1.12
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med (2013) 1.12
Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor. Proc Natl Acad Sci U S A (2011) 1.12
Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem (2009) 1.12
Structural basis for substrate fatty acyl chain specificity: crystal structure of human very-long-chain acyl-CoA dehydrogenase. J Biol Chem (2008) 1.12
Structural basis for RNA recognition by a dimeric PPR-protein complex. Nat Struct Mol Biol (2013) 1.12
Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin. J Biol Chem (2008) 1.11
Strategies for carbohydrate recognition by the mannose 6-phosphate receptors. Glycobiology (2008) 1.11
Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. J Biol Chem (2007) 1.10
Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E. Infect Immun (2005) 1.10
Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor. J Neurosci (2011) 1.09
Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. Brain Res (2006) 1.09
Recombinant holotoxoid vaccine against botulism. Infect Immun (2007) 1.09